<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id><journal-id journal-id-type="iso-abbrev">Proc Natl Acad Sci U S A</journal-id><journal-id journal-id-type="hwp">pnas</journal-id><journal-id journal-id-type="pmc">pnas</journal-id><journal-id journal-id-type="publisher-id">PNAS</journal-id><journal-title-group><journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title></journal-title-group><issn pub-type="ppub">0027-8424</issn><issn pub-type="epub">1091-6490</issn><publisher><publisher-name>National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7568326</article-id><article-id pub-id-type="publisher-id">202008087</article-id><article-id pub-id-type="doi">10.1073/pnas.2008087117</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>530</subject></subj-group><subj-group subj-group-type="heading"><subject>Biological Sciences</subject><subj-group><subject>Population Biology</subject></subj-group></subj-group></article-categories><title-group><article-title>Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0906-441X</contrib-id><name><surname>Brett</surname><given-names>Tobias S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="corresp" rid="cor1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7221-3801</contrib-id><name><surname>Rohani</surname><given-names>Pejman</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><aff id="aff1"><sup>a</sup>Odum School of Ecology, <institution>University of Georgia</institution>, Athens, <addr-line>GA</addr-line>, 30602;</aff><aff id="aff2"><sup>b</sup>Center for the Ecology of Infectious Diseases, <institution>University of Georgia</institution>, Athens, <addr-line>GA</addr-line>, 30602;</aff><aff id="aff3"><sup>c</sup>Department of Infectious Diseases, <institution>University of Georgia</institution>, Athens, <addr-line>GA</addr-line>, 30602</aff></contrib-group><author-notes><corresp id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <email>tsbrett@uga.edu</email>.</corresp><fn fn-type="edited-by"><p>Edited by Alan Hastings, University of California, Davis, CA, and approved August 27, 2020 (received for review April 26, 2020)</p></fn><fn fn-type="con"><p>Author contributions: T.S.B. and P.R. designed research; T.S.B. performed research; T.S.B. analyzed data; and T.S.B. and P.R. wrote the paper.</p></fn></author-notes><pub-date pub-type="ppub"><day>13</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>117</volume><issue>41</issue><fpage>25897</fpage><lpage>25903</lpage><permissions><copyright-statement>Copyright &#x000a9; 2020 the Author(s). Published by PNAS.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="vor">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This open access article is distributed under <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="pnas.202008087.pdf"/><abstract abstract-type="executive-summary"><title>Significance</title><p>Confronted with escalating COVID-19 outbreaks, countries at the leading edge of the pandemic have had to resort to imposing drastic social distancing measures which have serious societal and economic repercussions. Establishing herd immunity in a population by allowing the epidemic to spread, while mitigating the negative health impacts of COVID-19, presents a tantalizing resolution to the crisis. Our study simulating SARS-CoV-2 spread in the United Kingdom finds that achieving herd immunity without overwhelming hospital capacity leaves little room for error. Intervention levels must be carefully manipulated in an adaptive manner for an extended period, despite acute sensitivity to poorly quantified epidemiological factors. Such fine-tuning of social distancing renders this strategy impractical.</p></abstract><abstract><p>The rapid growth rate of COVID-19 continues to threaten to overwhelm healthcare systems in multiple countries. In response, severely affected countries have had to impose a range of public health strategies achieved via nonpharmaceutical interventions. Broadly, these strategies have fallen into two categories: 1) &#x0201c;mitigation,&#x0201d; which aims to achieve herd immunity by allowing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus to spread through the population while mitigating disease burden, and 2) &#x0201c;suppression,&#x0201d; aiming to drastically reduce SARS-CoV-2 transmission rates and halt endogenous transmission in the target population. Using an age-structured transmission model, parameterized to simulate SARS-CoV-2 transmission in the United Kingdom, we assessed the long-term prospects of success using both of these approaches. We simulated a range of different nonpharmaceutical intervention scenarios incorporating social distancing applied to differing age groups. Our modeling confirmed that suppression of SARS-CoV-2 transmission is possible with plausible levels of social distancing over a period of months, consistent with observed trends. Notably, our modeling did not support achieving herd immunity as a practical objective, requiring an unlikely balancing of multiple poorly defined forces. Specifically, we found that 1) social distancing must initially reduce the transmission rate to within a narrow range, 2) to compensate for susceptible depletion, the extent of social distancing must be adaptive over time in a precise yet unfeasible way, and 3) social distancing must be maintained for an extended period to ensure the healthcare system is not overwhelmed.</p></abstract><kwd-group><kwd>infectious diseases</kwd><kwd>mathematical modeling</kwd><kwd>dynamical systems</kwd></kwd-group><funding-group><award-group id="gs1"><funding-source id="sp1">HHS | NIH | National Institute of General Medical Sciences (NIGMS)<named-content content-type="funder-id">100000057</named-content></funding-source><award-id rid="sp1">5R01GM123007</award-id><principal-award-recipient>Tobias S Brett</principal-award-recipient><principal-award-recipient>Pejman Rohani</principal-award-recipient></award-group></funding-group><counts><page-count count="7"/></counts><custom-meta-group><custom-meta><meta-name>access-type</meta-name><meta-value>free</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p content-type="flushleft">Caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (<xref rid="r1" ref-type="bibr">1</xref>), COVID-19 is an infectious disease capable of severe respiratory illness and death (<xref rid="r2" ref-type="bibr">2</xref>). Since its identification in Wuhan, China, COVID-19 has become an on-going and rapidly expanding global pandemic that is causing substantial mortality and healthcare system strain in multiple countries (<xref rid="r3" ref-type="bibr">3</xref>). While older individuals and those with underlying conditions are most at risk (<xref rid="r4" ref-type="bibr">4</xref>), infection has been seen across age groups (<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref>). Worryingly, detection of viral loads in the upper respiratory tract suggests potential for presymptomatic and ogliosymptomatic transmission (<xref rid="r7" ref-type="bibr">7</xref><xref rid="r8" ref-type="bibr"/>&#x02013;<xref rid="r9" ref-type="bibr">9</xref>). Due to the absence of a vaccine, current attempts at controlling SARS-CoV-2 spread are focused on social measures that reduce rates of viral transmission: social distancing (a generalized reduction of contact rates between individuals in the population) and self-isolation by symptomatic individuals (<xref rid="r10" ref-type="bibr">10</xref>).</p><p>Broadly speaking, two distinct approaches to controlling the spread of SARS-CoV-2 have received much attention. The first aims to suppress transmission in the target population (referred to hereafter as &#x0201c;suppression&#x0201d;) (<xref rid="r10" ref-type="bibr">10</xref>). Under this objective, control measures reduce viral transmission to such a degree that sustained endogenous transmission is no longer possible. By maintaining control measures in place for a sufficient period of time, the virus will be eliminated in the focal population. The focus will then shift to preventing subsequent reintroduction to prevent resurgence. The second approach aims to manage or mitigate the negative health impacts (referred to hereafter as &#x0201c;mitigation&#x0201d;) (<xref rid="r10" ref-type="bibr">10</xref>). While suppression aims to ultimately halt local transmission, mitigation aims to reduce the growth rate of the epidemic to ensure disease burden does not overwhelm healthcare systems (<xref rid="r3" ref-type="bibr">3</xref>). By reducing (rather than halting) transmission, this strategy allows the susceptible pool to diminish, with the population potentially able to achieve herd immunity (whereby sustained local transmission is impossible, even without social distancing) (<xref rid="r11" ref-type="bibr">11</xref>). In practice, both approaches require the rollout of the same types of control measures (social distancing and self-isolation), although the necessary intensities and durations vary.</p><p>At the time of writing, trends in incidence data suggest multiple countries, including China, South Korea, Spain, and Italy, have successfully implemented suppression strategies (<xref rid="r12" ref-type="bibr">12</xref>). Sweden is the poster child for mitigation strategies, and appears to be aiming for herd immunity (<xref rid="r13" ref-type="bibr">13</xref>). Meanwhile, other countries continue to experience sustained transmission, and strategic intention is less clear [including the United States (<xref rid="r14" ref-type="bibr">14</xref>) and United Kingdom (<xref rid="r15" ref-type="bibr">15</xref>)]. The severe economic costs and acute societal pressures associated with social distancing measures have led to a push for their relaxation (<xref rid="r10" ref-type="bibr">10</xref>). Given the potentially long wait until a vaccine is available, the UK government appears to have considered following Sweden&#x02019;s example and attempt to achieve herd immunity in the country (<xref rid="r16" ref-type="bibr">16</xref>).</p><p>The consequences of failure to either adequately mitigate or suppress COVID-19 are potentially catastrophic. Due to the many uncertainties surrounding SARS-CoV-2 transmission, evolution, and immunity, public health decision makers are presented with an unenviable task. To help inform control policies under uncertainty, mathematical modeling can assist in evaluating the viability of mitigation and suppression as objectives (<xref rid="r17" ref-type="bibr">17</xref>), by simulating the impacts of control strategies on viral transmission, hospital burden, fatalities, and population-level immunity.</p><p>Recent studies have modeled impacts of both mitigation and suppression strategies, including for China (<xref rid="r18" ref-type="bibr">18</xref>), low-income countries (<xref rid="r19" ref-type="bibr">19</xref>), and the United Kingdom (<xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r21" ref-type="bibr">21</xref>). Crucially, we are not aware of any systematic studies that focus on 1) walking the tightrope of achieving herd immunity without overburdening healthcare systems and 2) the control effort (e.g., reduction in contacts) required for successful mitigation relative to suppression. These two knowledge gaps motivate our study. We use an age-stratified disease transmission model, taking the United Kingdom as an example, to simulate SARS-CoV-2 spread controlled by individual self-isolation and widespread social distancing. We simulated various levels of self-isolation effectiveness and three distinct types of social-distancing measures: 1) school (including university) closures, 2) work and social place closures, and 3) effective isolation by older individuals.</p><p>Our modeling confirms that suppression is possible with plausible levels of social distancing and self-isolation, consistent with experience in multiple countries. Our research does not, however, support attempting to mitigate COVID-19 with the aim of building herd immunity. Achieving herd immunity while simultaneously maintaining hospital burden at manageable levels requires adaptive fine-tuning of mitigation efforts, in the face of imperfect epidemiological intelligence&#x02014;something that is impractical.</p><sec sec-type="results" id="s1"><title>Results</title><p content-type="flushleft">In the absence of any intervention measures, our modeling suggests SARS-CoV-2 will spread rapidly through the United Kingdom (<xref ref-type="fig" rid="fig01">Fig. 1<italic>A</italic></xref>), and ultimately infect approximately 77% of the population (<xref ref-type="fig" rid="fig01">Fig. 1<italic>B</italic></xref>). Using data on the age-specific fatality rate of COVID-19 (<xref rid="r22" ref-type="bibr">22</xref>), our results show around 350,000 fatalities among individuals aged over 60 y, and around 60,000 aged below 60 y (<xref ref-type="fig" rid="fig01">Fig. 1<italic>C</italic></xref>). While we caution that our model makes a number of simplifying assumptions [e.g., no spatial dependence in transmission (<xref rid="r11" ref-type="bibr">11</xref>)], the total of fatalities is comparable to predictions made in other UK modeling studies (e.g., within the 95% prediction interval of ref. <xref rid="r20" ref-type="bibr">20</xref>).</p><fig id="fig01" fig-type="featured" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Simulated examples of SARS-CoV-2 spread in the United Kingdom using an age-structured Susceptible Exposed Infectious Recovered (SEIR) model under different control scenarios. (<italic>A</italic>) Daily new cases assuming no intervention measures enacted. (<italic>B</italic>) Cumulative proportion of the population exposed to SARS-CoV-2 over the course of the epidemic. (<italic>C</italic>) Cumulative fatalities assuming fixed age-specific case fatality rates (see <xref ref-type="sec" rid="s3"><italic>Materials and Methods</italic></xref>). (<italic>D</italic>&#x02013;<italic>F</italic>) Same as <italic>A</italic>&#x02013;<italic>C</italic>, but assuming that specific control measures are introduced when daily cases reached 10,000 (day 57): Older individuals social distance, and symptomatic individuals self-isolate (at 20% effectiveness). (<italic>G</italic>&#x02013;<italic>I</italic>) Same as <italic>D</italic>&#x02013;<italic>F</italic> but, in addition, schools close on day 57. Reopening of schools after 100 d results in a resurgence.</p></caption><graphic id="gra1" xlink:href="pnas.2008087117fig01"/></fig><p>Sustained social distancing by older individuals (assumed to result in a 90% reduction in contacts with individuals under 25 y old, a 70% reduction with 25- to 59-y-olds, and a 50% reduction between one another), and moderately effective self-isolation by symptomatic individuals (at 20% efficacy) results in a shallower epidemic curve (<xref ref-type="fig" rid="fig01">Fig. 1<italic>D</italic></xref>) and a much smaller outbreak size among individuals aged 60+ y (<xref ref-type="fig" rid="fig01">Fig. 1<italic>E</italic></xref>). The attendant mortality burden among 60+-y-old individuals is also substantially reduced (to 62,000), with a smaller reduction in fatalities in those aged <inline-formula><mml:math id="i1"><mml:mo>&#x0003c;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula> y (to 43,000; <xref ref-type="fig" rid="fig01">Fig. 1<italic>F</italic></xref>).</p><p>The addition of school (and university) closures, corresponding to a 70% reduction in contacts among school-aged individuals and a 20% reduction with 25- to 59-y-olds, dramatically reduces the rate of epidemic growth (<xref ref-type="fig" rid="fig01">Fig. 1<italic>G</italic></xref>), although such levels of control are insufficient to suppress the epidemic (i.e., the number of daily cases still rises after implementation). The premature reopening of schools after 100 d (while the virus is still circulating) triggers a second wave of infection, with only a moderately reduced peak in daily new cases, largely eroding any additional gains made (<xref rid="r23" ref-type="bibr">23</xref>). The final proportion of the population exposed (<xref ref-type="fig" rid="fig01">Fig. 1<italic>H</italic></xref>) and the number of fatalities (<xref ref-type="fig" rid="fig01">Fig. 1<italic>I</italic></xref>) are largely unaltered compared to if schools had not been closed (compare <xref ref-type="fig" rid="fig01">Fig. 1 <italic>E</italic> and <italic>F</italic></xref>).</p><p>Our modeling indicates that, if sustained, such control measures can lead to the suppression of COVID-19 in the United Kingdom by reducing <italic>R</italic><sub>0</sub> to &#x0003c;1 (<xref ref-type="fig" rid="fig02">Fig. 2 <italic>A</italic> and <italic>B</italic></xref>). The effectiveness of self-isolation by symptomatic individuals (i.e., its impact on reducing overall transmission) is a product of two factors. Firstly, the proportion of infections generated while the primary case is exhibiting symptoms (including mild symptoms) and, secondly, the engagement of symptomatic individuals with self-isolation policies (see <xref ref-type="sec" rid="s3"><italic>Materials and Methods</italic></xref>). As both of these parameters decrease, the self-isolation efficacy drops, and greater social distancing measures are necessary to achieve suppression (<xref ref-type="fig" rid="fig02">Fig. 2<italic>A</italic></xref>). At present, there is a large uncertainty in the relationship between symptoms and viral shedding (<xref rid="r9" ref-type="bibr">9</xref>). For the social distancing strengths considered, suppression is possible if over 14% of infections are caused while the primary case is exhibiting symptoms (<inline-formula><mml:math id="i2"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). The associated self-isolation observance necessary to achieve suppression is inversely proportional to <inline-formula><mml:math id="i3"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, decreasing from 100% if <inline-formula><mml:math id="i4"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.14</mml:mn></mml:math></inline-formula> to 50% if <inline-formula><mml:math id="i5"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.28</mml:mn></mml:math></inline-formula>. Given the uncertainty surrounding asymptomatic transmission, the likelihood of successful suppression is greatest if all social distancing measures are enacted (<xref ref-type="fig" rid="fig02">Fig. 2<italic>B</italic></xref>).</p><fig id="fig02" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Prospects for disease suppression. Simulations of the age-structured SEIR model performed assuming control measures are initiated when there is a total of 10,000 infectious individuals in the population. The different control measures and strengths are listed in <xref ref-type="sec" rid="s3"><italic>Materials and Methods</italic></xref>. (<italic>A</italic>) Whether suppression is possible depends on both the self-isolation observance rate and the proportion of infections due to symptomatic individuals. More extensive social distancing measures increase the ranges of these two parameters for which suppression is possible. (<italic>B</italic>) Increases in self-isolation effectiveness drive down the reproductive number, which also depends on the social distancing measures employed. (<italic>C</italic>) The time taken for COVID-19 to be suppressed (modeled as a 100-fold reduction in infectious individuals) depends on the amount the reproductive number is decreased below one.</p></caption><graphic id="gra2" xlink:href="pnas.2008087117fig02"/></fig><p>The time taken for suppression to be achieved (modeled as a 100-fold reduction in infectious individuals) once control measures are implemented is shown in <xref ref-type="fig" rid="fig02">Fig. 2<italic>C</italic></xref>. If self-isolation effectiveness is high (<inline-formula><mml:math id="i6"><mml:mo>&#x0003e;</mml:mo></mml:math></inline-formula>70% reduction in transmission), then suppression can be achieved in 2 mo regardless of any additional social distancing measures. There is little additional decrease in the necessary duration of social distancing unless schools and workplaces are both closed, in which case suppression can be achieved within 2 mo at much lower levels of self-isolation effectiveness (<inline-formula><mml:math id="i7"><mml:mo>&#x02273;</mml:mo></mml:math></inline-formula>45%).</p><p>If suppression cannot be achieved (due to unfeasibility or lack of political will to reduce transmission sufficiently), then the objective of control measures is mitigation. Social distancing by 60+-y-old individuals results in a marked reduction of the final fraction of this age group that are exposed; however, unless both schools and workplaces are closed, additional social distancing measures do not lead to much further reduction (<xref ref-type="fig" rid="fig03">Fig. 3<italic>A</italic></xref>).</p><fig id="fig03" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Outcomes of disease mitigation attempts, simulated using the age-structured SEIR model. As in <xref ref-type="fig" rid="fig02">Fig. 2</xref>, control measures are implemented when there are 10,000 cases in the population. (<italic>A</italic>) The final fraction of 60+-y-old individuals exposed to COVID-19 for each of the control strategies simulated, assuming that social distancing measures can be maintained at the same strength indefinitely (&#x0201c;without fatigue&#x0201d;). (<italic>B</italic>) Size and (<italic>C</italic>) timing of the peak in daily new cases among 60+-y-old individuals. (<italic>D</italic>) Peak hospital burden, assuming age-specific hospitalization rates (see <xref ref-type="sec" rid="s3"><italic>Materials and Methods</italic></xref>) and a mean hospital stay of 7 d (<xref rid="r24" ref-type="bibr">24</xref>). (<italic>E</italic>&#x02013;<italic>H</italic>) Simulation results using the same control strategies as in <italic>A</italic>&#x02013;<italic>D</italic>, but assuming that, due to fatigue, schools and workplaces closures last 100 d.</p></caption><graphic id="gra3" xlink:href="pnas.2008087117fig03"/></fig><p>These results are also mirrored in the impacts of social distancing on the daily cases in 60+-y-old individuals (<xref ref-type="fig" rid="fig03">Fig. 3<italic>B</italic></xref>). Unfortunately, the hospital burden remains high for most intervention strategies, unless self-isolation is very effective (<inline-formula><mml:math id="i8"><mml:mo>&#x02273;</mml:mo><mml:mn>50</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula>; <xref ref-type="fig" rid="fig03">Fig. 3<italic>D</italic></xref>). Taking around 100,000 hospitalized cases to be the upper limit of hospital capacity, we find that there is a relatively small range of parameters where mitigation is successful at preventing hospitals being overwhelmed, but the disease is not also successfully suppressed (<xref ref-type="fig" rid="fig03">Fig. 3<italic>D</italic></xref>; compare to <xref ref-type="fig" rid="fig02">Fig. 2<italic>B</italic></xref>). If social distancing is applied to all age groups, this range is 0 to 14% self-isolation effectiveness, whereas, if just the 60+-y age group socially distance, the range is 41 to 54%.</p><p>As mentioned previously, if schools and workplaces reopen simultaneously after 100 d [e.g., due to social distancing &#x0201c;fatigue&#x0201d; (<xref rid="r10" ref-type="bibr">10</xref>)] and the disease has not been successfully suppressed, then much of the benefit of their closure is lost (<xref ref-type="fig" rid="fig03">Fig. 3 <italic>E</italic>&#x02013;<italic>H</italic></xref>) due to a resurgent second wave. In this scenario, the principle effect of school and workplace closures is in delaying the peak, buying more time for preparations (<xref ref-type="fig" rid="fig03">Fig. 3G</xref>).</p><p>It has been suggested that children might have reduced susceptibility to infection with SARS-CoV-2 (<xref rid="r25" ref-type="bibr">25</xref>). We repeated our analysis of suppression and mitigation assuming 50% reduction in susceptibility of individuals under 20 y old, with transmission rates among adults increased to ensure the same reproductive number, <inline-formula><mml:math id="i9"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2.3</mml:mn></mml:math></inline-formula>. As might be expected, there is a decreased impact of school closures; however, this is compensated by the increased impact of social distancing by over-20-y-olds, resulting in little net change in our findings if both work and school closures occur (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Figs. S1 and S2</ext-link>).</p><p>To summarize, aiming to build herd immunity to SARS-CoV-2 in a population while mitigating the burden on hospitals requires initially reducing the reproductive number to ensure available hospital capacity is not exceeded (<xref ref-type="fig" rid="fig04">Fig. 4<italic>A</italic></xref>). If social distancing is maintained at a fixed level, hospital capacity needs to be much larger than presently available to achieve herd immunity without exceeding capacity; otherwise, the final outbreak size will be insufficient to achieve herd immunity (<xref ref-type="fig" rid="fig04">Fig. 4<italic>B</italic></xref>). Relaxing social distancing measures linearly is also insufficient (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S3</ext-link>).</p><fig id="fig04" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Summary of prospects for achieving herd immunity. (<italic>A</italic>) The peak hospital burden (shown on a log scale) is highly sensitive to the reproductive number. There is a narrow window of reproductive number values (shaded) where either 1) the number of COVID-19 cases requiring hospitalization does not overwhelm hospital capacity (modeled at the average hospital burden for April, 17,800 beds) or 2) circulation is suppressed. This window depends subtly on the exact age-specific social distancing configuration; however, all strategies studied fall between the two curves shown. (<italic>B</italic>) None of the simulated control scenarios shown in <xref ref-type="fig" rid="fig02">Figs. 2</xref> and <xref ref-type="fig" rid="fig03">3</xref> achieved herd immunity while also keeping cases below hospital capacity. For the parameters considered, a hospital capacity in excess of 300,000 is required for this to be possible&#x02014;almost 3 times the total UK NHS hospital beds (around 125,000 beds; see <xref ref-type="sec" rid="s3"><italic>Materials and Methods</italic></xref>), and around 15 times the average hospital burden of April.</p></caption><graphic id="gra4" xlink:href="pnas.2008087117fig04"/></fig><p>Instead, achieving herd immunity without exceeding hospital capacity requires that social distancing is implemented nonlinearly. An idealized optimal strategy for achieving social distancing, calculated using a two-age group (<inline-formula><mml:math id="i10"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60 y old and <inline-formula><mml:math id="i11"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60 y old) SEIR model, is shown in <xref ref-type="fig" rid="fig05">Fig. 5 <italic>A</italic> and <italic>B</italic></xref>. We assumed that individuals <inline-formula><mml:math id="i12"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60 y old were able to perfectly self-isolate, while herd immunity is built up in the <inline-formula><mml:math id="i13"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y age group. The epidemic in <inline-formula><mml:math id="i14"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-old individuals is initially allowed to grow unimpeded until the hospital burden caused by the number of sick individuals reaches the hospital capacity. At this point, social distancing among those younger than 60 y commences (<xref ref-type="fig" rid="fig05">Fig. 5<italic>B</italic></xref>), at a level that ensures the epidemic growth stalls (i.e., <inline-formula><mml:math id="i15"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>). To achieve herd immunity in minimal time, the rate of new infections must then remain at the maximum afforded by the healthcare capacity. This requires reducing social distancing (i.e., increasing contacts) at the exact rate to balance out reductions in transmission stemming from the decreasing susceptible population (<xref ref-type="fig" rid="fig05">Fig. 5<italic>B</italic></xref>)&#x02014;too quickly and the epidemic grows above hospital capacity; too slowly and the epidemic with die out without reaching herd immunity. Over time, social distancing in <inline-formula><mml:math id="i16"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-olds drops to zero, after which there are no longer enough susceptible <inline-formula><mml:math id="i17"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-old individuals for the epidemic to be sustained. New infections continue but decline in frequency (meanwhile, further decreasing the effective reproductive number), before reaching zero.</p><fig id="fig05" fig-type="figure" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p>Proof-of-principle strategy for achieving herd immunity. This strategy 1) achieves herd immunity with minimal social distancing duration 2) without exceeding hospital capacity, and 3) prevents infection among the most vulnerable. We simulated a reduced two-age group (<inline-formula><mml:math id="i18"><mml:mo>&#x0003c;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula> y old and <inline-formula><mml:math id="i19"><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula> y old) model, assuming that all <inline-formula><mml:math id="i20"><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula>-y-old individuals completely isolate. (<italic>A</italic>) To achieve herd immunity in the minimum time requires control measures that fix the rate of new hospitalized cases to ensure hospital beds are at the maximum acceptable capacity until herd immunity is achieved (results showing taking capacity to be 1<inline-formula><mml:math id="i21"><mml:mo>&#x000d7;</mml:mo></mml:math></inline-formula> and 2<inline-formula><mml:math id="i22"><mml:mo>&#x000d7;</mml:mo></mml:math></inline-formula> the average hospital burden of April). (<italic>B</italic>) The reduction in contacts (via the product of self-isolation and social distancing) among <inline-formula><mml:math id="i23"><mml:mo>&#x0003c;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula>-y-olds needs to vary nonlinearly. Until the hospital burden hits the hospital capacity, there is no social distancing; subsequently, it is tuned to ensure <inline-formula><mml:math id="i24"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>; that is, the epidemic neither grows nor shrinks. Contact rates have to then gradually increase to exactly balance the reduction in <inline-formula><mml:math id="i25"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> due to susceptible depletion. Eventually, there are no longer enough <inline-formula><mml:math id="i26"><mml:mo>&#x0003c;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula>-y-old susceptible individuals to sustain the epidemic, and <inline-formula><mml:math id="i27"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>. (<italic>C</italic>) While this strategy ensures that the final reproductive number drops below 1 if individuals <inline-formula><mml:math id="i28"><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula> y old remain in isolation, if they return to pre-COVID-19 contact rates, then whether the reduction in susceptibles is sufficient to achieve herd immunity depends on the hospital capacity. The greater the proportion of the population that needs protecting, the greater the hospital capacity needed to achieve herd immunity. (<italic>D</italic>) The duration of social distancing also depends on the available hospital capacity. For the parameters considered, if hospital capacity is less than around 20,000, then it is not possible to achieve herd immunity without individuals aged <inline-formula><mml:math id="i29"><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula> y remaining socially distanced.</p></caption><graphic id="gra5" xlink:href="pnas.2008087117fig05"/></fig><p>While, at this point, the effective reproductive number is below 1 without any social distancing in the <inline-formula><mml:math id="i30"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y age group, full herd immunity has not necessarily been achieved (<xref ref-type="fig" rid="fig05">Fig. 5<italic>C</italic></xref>). If <inline-formula><mml:math id="i31"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-year-olds cease self-isolating, then the increased contact rates cause the effective reproductive number to increase, and may take it above 1. Achieving herd immunity requires that, while <inline-formula><mml:math id="i32"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-y-olds are isolated, the additional new infections after <inline-formula><mml:math id="i33"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula> sufficiently further reduce <inline-formula><mml:math id="i34"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (the &#x0201c;overshoot&#x0201d;) such that, when <inline-formula><mml:math id="i35"><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:math></inline-formula>-y-olds cease self-isolation, it remains below 1. The amount of overshoot increases with the hospital capacity (<xref ref-type="fig" rid="fig05">Fig. 5<italic>C</italic></xref>). In addition to increasing the prospects of achieving herd immunity (and also its robustness; see also <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S3<italic>C</italic></ext-link>), the necessary duration of social distancing is inversely proportional to hospital capacity (<xref ref-type="fig" rid="fig05">Fig. 5<italic>D</italic></xref>).</p><p>Our modeling required estimates for the case hospitalization probability (<xref rid="r22" ref-type="bibr">22</xref>) and mean hospitalization stay (<xref rid="r24" ref-type="bibr">24</xref>). We explored sensitivity of the duration of social distancing to these two parameters, and also performed a comparison with a rough calculation of the duration based on estimates of seroprevalance at the end of April (<xref rid="r26" ref-type="bibr">26</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S4</ext-link>). Our estimated necessary social distancing duration of 12 mo is close to the estimate from serology of 7 mo to 11 mo, especially considering the uncertainty in the case hospitalization probability (<xref rid="r22" ref-type="bibr">22</xref>).</p><p>Throughout our analysis, we used <inline-formula><mml:math id="i36"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2.3</mml:mn></mml:math></inline-formula>, broadly in line with most early estimates; however, some estimates were higher. We repeated our analysis using <inline-formula><mml:math id="i37"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>5.7</mml:mn></mml:math></inline-formula> (<xref rid="r27" ref-type="bibr">27</xref>), finding that, as might be expected, the range of intervention parameters that led to successful suppression was reduced (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S5</ext-link>). However, our main finding was reinforced: Higher values of <inline-formula><mml:math id="i38"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> narrow the window for successful mitigation (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6</ext-link>).</p></sec><sec sec-type="discussion" id="s2"><title>Discussion</title><p content-type="flushleft">Various governments have entertained the idea of achieving herd immunity through natural infection as a means of ending the long-term threat of COVID-19. This has provoked alarm in sections of the public health community (<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r28" ref-type="bibr">28</xref>). Our work confirms that this alarm is well founded.</p><p>Attempting to achieve herd immunity while simultaneously mitigating the impact of COVID-19 on hospital burden is an extremely challenging task. In order to ensure the hospital burden does not exceed levels comparable with that of the United Kingdom in April 2020, <inline-formula><mml:math id="i39"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> needs to be reduced from its initial value (assumed to be <inline-formula><mml:math id="i40"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2.3</mml:mn></mml:math></inline-formula>) to about 1.2. Suppression is possible if <inline-formula><mml:math id="i41"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is reduced below 1. Due to the fine margins (in terms of control effectiveness) between successful disease suppression and overwhelming hospitals, making herd immunity the primary objective (rather than applying maximal social distancing and aiming for suppression) is not supported by our modeling. Put another way, mitigation (via &#x0201c;flattening the curve&#x0201d;) is not a practical objective: If mitigation efforts are sufficient to prevent hospitals from being overwhelmed, only a comparatively small further increase in control measures will drive <inline-formula><mml:math id="i42"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> below 1, and make suppression possible.</p><p>If herd immunity is the objective, then, in addition to the narrow range of <inline-formula><mml:math id="i43"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> that must be aimed for, social distancing measures must be subsequently relaxed gradually in a highly controlled manner over a period of months to years. We were able to find a mathematical solution for building herd immunity with the minimal duration of social distancing using a reduced two-age group model. This solution requires knowledge of unobserved epidemiological determinants, namely, the remaining susceptible population, fraction exposed, and hospitalization probability. Additionally, complexities neglected by the model (e.g., failure of the <inline-formula><mml:math id="i44"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-y age group to completely isolate, spatial structure) will alter the exact social distancing function. We, instead, view our results as serving as an indicator of the general shape and duration of social distancing necessary. Developing methods for implementable social distancing strategies capable of building toward herd immunity and that rely only on observable epidemiological data (e.g., the incidence curve and the hospital bed occupancy) requires further research.</p><p>The estimates of hospitalization probability and fatalities were calculated using results from a study of cases in Wuhan, China (<xref rid="r22" ref-type="bibr">22</xref>). For this study, we took the point estimates; however, these had uncertainties associated with them and are unlikely to be the same across regions. Furthermore, as treatment of COVID-19 continues to improve, fatality rates will fall. While there is an obvious feedback between fatality rates and healthcare system burden, the extent to which the Wuhan healthcare system (used in estimation) was overwhelmed is unclear. We therefore assumed the fatality rates fixed regardless of hospital burden. For these reasons, we have avoided attaching confidence intervals to estimates of fatalities, and they should be interpreted as plausible projections and not predictions.</p><p>A major unknown remains the nature, duration, and effectiveness of natural immunity. Here, we made the pragmatic assumption that, over the time scales under consideration, infection confers perfect long-lasting immunity (the best-case scenario for mitigation strategies). If immunity is not perfect, and there is a moderate to high chance of reinfection, then prospects for achieving herd immunity via natural infection are slim (<xref rid="r29" ref-type="bibr">29</xref>). To shed light on the kinetics of immunity, mass longitudinal antibody testing is necessary. This would both permit the identification of previously infected individuals, and provide information regarding immunity through time (<xref rid="r30" ref-type="bibr">30</xref>). We submit that models such as the one explored here, when integrated into statistical inference algorithms (<xref rid="r31" ref-type="bibr">31</xref>), provide a powerful means of integrating parallel serological and epidemiological data streams to quantify population-level immunity. Further, such models can be central to the development of efficient age-stratified serological testing schemes.</p><p>Finally, we stress that our study only explored the epidemiological impacts of nonpharmaceutical interventions (social distancing and self-isolation). Ultimately, any comprehensive public health policy needs to take into account the concomitant and wide-ranging societal and economic consequences of control measures.</p></sec><sec sec-type="materials|methods" id="s3"><title>Materials and Methods</title><sec id="s4"><title>Model.</title><p>We used a deterministic age-structured SEIR transmission model to simulate COVID-19 transmission in the United Kingdom. Contact rates <inline-formula><mml:math id="i45"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, the number of daily contacts an individual of age <inline-formula><mml:math id="i46"><mml:mi>i</mml:mi></mml:math></inline-formula> y makes with individuals of age <inline-formula><mml:math id="i47"><mml:mi>j</mml:mi></mml:math></inline-formula> y, were taken from the POLYMOD study of social mixing patterns for the United Kingdom (<xref rid="r32" ref-type="bibr">32</xref>) corrected for reciprocity (<xref rid="r33" ref-type="bibr">33</xref>). The simulated age groups were matched to those of the POLYMOD study: 14 5-y increments from 0 y to 69 y and then 70+ y. Age-stratified population sizes (<inline-formula><mml:math id="i48"><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) were taken from 2018 UK demographic data.</p><p>The mean latent and infectious periods were set to <inline-formula><mml:math id="i49"><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>&#x003c1;</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:math></inline-formula> and <inline-formula><mml:math id="i50"><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>&#x003b3;</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:math></inline-formula> d, respectively, consistent with various estimates of the serial interval (<xref rid="r34" ref-type="bibr">34</xref>, <xref rid="r35" ref-type="bibr">35</xref>) and incubation period (<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r36" ref-type="bibr">36</xref>, <xref rid="r37" ref-type="bibr">37</xref>), assuming infectiousness starts 1 d to 2 d before symptoms develop.</p><p>Both latent and infectious periods were assumed to be gamma distributed and modeled using the method of stages (<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r38" ref-type="bibr">38</xref>, <xref rid="r39" ref-type="bibr">39</xref>), by dividing the exposed (<inline-formula><mml:math id="i51"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and infectious (<inline-formula><mml:math id="i52"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) compartments for each age group into four subcompartments, <inline-formula><mml:math id="i53"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="i54"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:math></inline-formula>, where the superscript labels the subcompartment. The transmission dynamics for the age groups were governed by a system of ordinary differential equations,<disp-formula id="eq1"><mml:math id="me1"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:math><label>[1]</label></disp-formula><disp-formula id="eq2"><mml:math id="me2"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003c1;</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:math><label>[2]</label></disp-formula><disp-formula id="eq3"><mml:math id="me3"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003c1;</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>&#x02212;</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003c1;</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mtext>for</mml:mtext><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo></mml:math><label>[3]</label></disp-formula><disp-formula id="eq4"><mml:math id="me4"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003c1;</mml:mi><mml:msubsup><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>4</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>&#x02212;</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003b3;</mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:math><label>[4]</label></disp-formula><disp-formula id="eq5"><mml:math id="me5"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003b3;</mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>&#x02212;</mml:mo><mml:mn>4</mml:mn><mml:mi>&#x003b3;</mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mtext>for</mml:mtext><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo></mml:math><label>[5]</label></disp-formula><disp-formula id="eq6"><mml:math id="me6"><mml:msub><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>&#x003b2;</mml:mi><mml:munder><mml:mrow><mml:mo largeop="true" movablelimits="false" symmetric="true">&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:math><label>[6]</label></disp-formula>The transmission rate <inline-formula><mml:math id="i55"><mml:mi>&#x003b2;</mml:mi></mml:math></inline-formula> was tuned using the next-generation matrix (<xref rid="r40" ref-type="bibr">40</xref>) to give a value of <inline-formula><mml:math id="i56"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2.3</mml:mn></mml:math></inline-formula>, consistent with estimates (<xref rid="r34" ref-type="bibr">34</xref>, <xref rid="r35" ref-type="bibr">35</xref>). Simulations were initialized with one initial introduction in a fully susceptible population (<inline-formula><mml:math id="i57"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). The resulting doubling time was observed to be about 3 d, broadly consistent with early observations from the United Kingdom.</p></sec><sec id="s5"><title>Modeling Nonpharmaceutical Interventions.</title><p>Two types of nonpharmaceutical intervention were modeled: 1) self-isolation by symptomatic infectious individuals and 2) mass social distancing by differing age groups (<xref ref-type="fig" rid="fig06">Fig. 6</xref>). The effectiveness of self-isolation of symptomatic individuals is dependent on the product of two factors: 1) the proportion of infections that occur due to symptomatic individuals (excluding both presymptomatic and asymptomatic transmission), <inline-formula><mml:math id="i58"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, and 2) the observance rate of social isolation among symptomatic individuals, <inline-formula><mml:math id="i59"><mml:mi>k</mml:mi></mml:math></inline-formula>. The fractional reduction of contacts between age groups <inline-formula><mml:math id="i60"><mml:mi>i</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="i61"><mml:mi>j</mml:mi></mml:math></inline-formula> due to social distancing is given by <inline-formula><mml:math id="i62"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>.</p><fig id="fig06" fig-type="figure" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p>Modeling the impact of nonpharmaceutical interventions on disease transmission. (<italic>A</italic>) Different social distancing measures (e.g., school closures, work and social place closures, and older individuals distancing) reduce contact rates between individuals in different ways. To reduce the complexity of the model, and to understand their differential impacts, we assume that individuals are only affected by one of these measures, dependent on their age. Individuals aged 0 y to 24 y are affected by school closures (included in this are university closures). School closures were assumed to result in a 70% reduction in contacts among school-aged individuals (<inline-formula><mml:math id="i63"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>Y</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and 20% reduction in their contacts with individuals aged 25 y to 59 y (<inline-formula><mml:math id="i64"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). Work and social place closures were assumed to reduce contacts among adults (<inline-formula><mml:math id="i65"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) by 50%. Finally, older individuals distancing reduced contacts by 60+-y-old individuals with 0- to 24-y-olds by 90% (<inline-formula><mml:math id="i66"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), with 25- to 59-y-olds by 70% (<inline-formula><mml:math id="i67"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), and among one another by 50% (<inline-formula><mml:math id="i68"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). The effectiveness of symptomatic individuals self-isolating is dependent on two factors: 1) the observance by symptomatic individuals, <inline-formula><mml:math id="i69"><mml:mi>k</mml:mi></mml:math></inline-formula>, and 2) the proportion of transmission due to individuals who are symptomatic, <inline-formula><mml:math id="i70"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. (<italic>B</italic>) We modeled five distinct combinations of social distancing measures, assuming that older individuals&#x02019; social distancing will always be prioritized.</p></caption><graphic id="gra6" xlink:href="pnas.2008087117fig06"/></fig><p>Both of these interventions take the form of modifications to the contact matrix between infectious and susceptible individuals,<disp-formula id="eq7"><mml:math id="me7"><mml:msub><mml:mrow><mml:mover accent="false"><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mo>&#x0007e;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>k</mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math><label>[7]</label></disp-formula>This expression for <inline-formula><mml:math id="i71"><mml:msub><mml:mrow><mml:mover accent="false"><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mo>&#x0007e;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is inserted in place of <inline-formula><mml:math id="i72"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in <xref ref-type="disp-formula" rid="eq6">Eq. <bold>6</bold></xref>.</p><p>Age groups in the model are divided into whether they are young (<inline-formula><mml:math id="i73"><mml:mi>Y</mml:mi></mml:math></inline-formula>; corresponding to 0- to 24-y-olds and age groups <inline-formula><mml:math id="i74"><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula> to 4), adults (<inline-formula><mml:math id="i75"><mml:mi>A</mml:mi></mml:math></inline-formula>; 25- to 59-y-olds, age groups <inline-formula><mml:math id="i76"><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>5</mml:mn></mml:math></inline-formula> to 11) and older (<inline-formula><mml:math id="i77"><mml:mi>O</mml:mi></mml:math></inline-formula>; 60+-y-olds, age groups <inline-formula><mml:math id="i78"><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>12</mml:mn></mml:math></inline-formula> to 15). The reduction in contacts due to social distancing, <inline-formula><mml:math id="i79"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, is then determined by which of these three categories the contacter and contactee fall into, given by the block matrix<disp-formula id="eq8"><mml:math id="me8"><mml:mi>q</mml:mi><mml:mo>=</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mtable align="axis" equalrows="false" columnlines="none none none none none none none none none" equalcolumns="false" class="array"><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>Y</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><label>[8]</label></disp-formula>We assume school closures reduce contact rates between young individuals by a factor of <inline-formula><mml:math id="i80"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>Y</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:math></inline-formula> and between young people and adults by <inline-formula><mml:math id="i81"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:math></inline-formula>. Social distancing among adults (e.g., due to workplace closures and reduction in social events) was modeled as a reduction of <inline-formula><mml:math id="i82"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:math></inline-formula>. Social distancing of older individuals was represented by <inline-formula><mml:math id="i83"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>O</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9</mml:mn></mml:math></inline-formula>, <inline-formula><mml:math id="i84"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:math></inline-formula>, and <inline-formula><mml:math id="i85"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi><mml:mi>O</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:math></inline-formula>. For simulations with social distancing fatigue, <inline-formula><mml:math id="i86"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>Y</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, <inline-formula><mml:math id="i87"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>&#x02009;</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="i88"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> were modeled as linearly decreasing from these initial values to 0 over the periods indicated in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S3</ext-link>.</p></sec><sec id="s6"><title>Estimating Hospital Burden and Case Fatalities.</title><p>Age-specific hospitalization probabilities, <inline-formula><mml:math id="i89"><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, and fatality rates were taken from point estimates calculated in a study of cases in Wuhan, China (<xref rid="r22" ref-type="bibr">22</xref>). Due to differences in the final age group of our model (70+ y) and those of the Wuhan study (70- to 79-y-olds and 80+-y-olds), the hospitalization and fatality rates for 70+-y-old individuals were calculated by summing the estimated 70- to 79-y-old and 80+-y-old rates weighted by their relative UK population sizes. Based on data from the United Kingdom, we assumed the average duration of hospitalization with COVID-19, <inline-formula><mml:math id="i90"><mml:mi>d</mml:mi></mml:math></inline-formula>, was 7 d (<xref rid="r24" ref-type="bibr">24</xref>).</p><p>Pre&#x02013;COVID-19 hospital beds and occupancy rates in the UK National Health Systems (NHS) were taken from the most recent (autumn 2019) published numbers for Northern Ireland, Wales, Scotland, and England.</p><p>Hospital burden was calculated as <inline-formula><mml:math id="i91"><mml:mi>H</mml:mi><mml:mo>=</mml:mo><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#x0039b;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Although there is a lag between exposure and hospitalization, this has no bearing on our mathematical results.</p></sec><sec id="s7"><title>Optimal Strategy to Achieve Herd Immunity.</title><p>We used a two-age group model (<inline-formula><mml:math id="i92"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-olds and <inline-formula><mml:math id="i93"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-y-olds) to demonstrate an optimal social distancing strategy while shielding <inline-formula><mml:math id="i94"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-y-old individuals. To preserve the data-informed contact structure, we made the approximation that the age-specific incidence was constant for age groups <inline-formula><mml:math id="i95"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60 y and similarly for <inline-formula><mml:math id="i96"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60 y. The two-age group contact matrix is then given by a weighted sum of the POLYMOD-derived contact matrix, <inline-formula><mml:math id="i97"><mml:msubsup><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, where <inline-formula><mml:math id="i98"><mml:mi>a</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="i99"><mml:mi>b</mml:mi></mml:math></inline-formula> index age groups <inline-formula><mml:math id="i100"><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mo>&#x0003c;</mml:mo><mml:mn>60</mml:mn><mml:mo>,</mml:mo><mml:mo>&#x02265;</mml:mo><mml:mn>60</mml:mn></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>. Aside from the contact matrix, the model is identical in structure to that given in <xref ref-type="disp-formula" rid="eq1">Eqs. <bold>1</bold></xref>&#x02013;<xref ref-type="disp-formula" rid="eq6"><bold>6</bold></xref>.</p><p>If <inline-formula><mml:math id="i101"><mml:mo>&#x02265;</mml:mo></mml:math></inline-formula>60-y-old individuals are shielded (contact rates reduced to zero), the <inline-formula><mml:math id="i102"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-old susceptible population is depleted at the fastest rate if the epidemic is allowed to grow unimpeded until the hospital burden (as defined above) reaches the hospital capacity, <inline-formula><mml:math id="i103"><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. At this point, contact rates are reduced to maintain hospital burden at hospital capacity. Mathematically, this translates into setting the reduction in contacts, <inline-formula><mml:math id="i104"><mml:mi>q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula>, such that <xref ref-type="disp-formula" rid="eq2">Eqs. <bold>2</bold></xref>&#x02013;<xref ref-type="disp-formula" rid="eq5"><bold>5</bold></xref> all equal 0. Solving for <inline-formula><mml:math id="i105"><mml:mi>q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> gives<disp-formula id="eq9"><mml:math id="me9"><mml:mi>q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfenced open="{" close=""><mml:mrow><mml:mtable align="axis" equalrows="false" columnlines="none" equalcolumns="false" class="array"><mml:mtr><mml:mtd columnalign="left"><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mtext>if</mml:mtext><mml:mi>H</mml:mi><mml:mo>&#x02265;</mml:mo><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mtext>and</mml:mtext><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x0003e;</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="left"><mml:mtext mathvariant="normal">otherwise</mml:mtext><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math><label>[9]</label></disp-formula>where <inline-formula><mml:math id="i106"><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">ff</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>&#x003b3;</mml:mi><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>&#x003b2;</mml:mi><mml:msubsup><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mn>0,0</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the effective reproductive number without contact reduction by <inline-formula><mml:math id="i107"><mml:mo>&#x0003c;</mml:mo></mml:math></inline-formula>60-y-olds. Substituting <xref ref-type="disp-formula" rid="eq9">Eq. <bold>9</bold></xref> into <xref ref-type="disp-formula" rid="eq1">Eq. <bold>1</bold></xref> and solving gives an expression for the control duration, <inline-formula><mml:math id="i108"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. For the parameters considered, there is limited susceptible depletion prior to hospital capacity being reached, and so<disp-formula id="eq10"><mml:math id="me10"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02248;</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003b2;</mml:mi><mml:msubsup><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mn>0,0</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><label>[10]</label></disp-formula></p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data"><label>Supplementary File</label><media xlink:href="pnas.2008087117.sapp.pdf"/></supplementary-material></sec></body><back><ack><p>This work is funded by the NIH through Models of Infectious Disease Agent Study Grant 5R01GM123007.</p></ack><fn-group><fn fn-type="COI-statement"><p>The authors declare no competing interest.</p></fn><fn fn-type="other"><p>This article is a PNAS Direct Submission.</p></fn><fn fn-type="supplementary-material"><p>This article contains supporting information online at <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental" xlink:show="new">https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2008087117/-/DCSupplemental</ext-link>.</p></fn></fn-group><sec id="s8" sec-type="data-availability"><title>Data Availability.</title><p>Source code data have been deposited in Zenodo (<ext-link ext-link-type="uri" xlink:href="http://doi.org/10.5281/zenodo.4000983" xlink:show="new">10.5281/zenodo.400093</ext-link>) (<xref rid="r41" ref-type="bibr">41</xref>).</p></sec><ref-list><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>N.</given-names></name><etal/></person-group>, <article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title>. <source>N. Engl. J. Med.</source>
<volume>328</volume>, <fpage>727</fpage>&#x02013;<lpage>733</lpage> (<year>2020</year>).</mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><etal/></person-group>, <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>497</fpage>&#x02013;<lpage>506</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bedford</surname><given-names>J.</given-names></name><etal/></person-group>, <article-title>COVID-19: Towards controlling of a pandemic</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>1015</fpage>&#x02013;<lpage>1018</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32197103</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>W.-J.</given-names></name><etal/></person-group>, <article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>
<fpage>1708</fpage>&#x02013;<lpage>1720</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><etal/></person-group>, <article-title>Detection of COVID-19 in children in early January 2020 in Wuhan, China</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, <fpage>1370</fpage>&#x02013;<lpage>1371</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32163697</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>Q.</given-names></name><etal/></person-group>, <article-title>Epidemiology and transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts</article-title>. <comment>medRxiv:10.1101/2020.03.03.20028423 (27 March 2020)</comment>.</mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>L.</given-names></name><etal/></person-group>, <article-title>SARS-CoV-2 viral load in upper respiratory specimens of infected patients</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, <fpage>1177</fpage>&#x02013;<lpage>1179</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>W. E.</given-names></name><etal/></person-group>, <article-title>Presymptomatic transmission of SARS-CoV-2&#x02014;Singapore, January 23&#x02013;March 16, 2020</article-title>. <source>MMWR (Morb. Mortal. Wkly. Rep.)</source>
<volume>69</volume>, <fpage>411</fpage>&#x02013;<lpage>415</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32271722</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>W&#x000f6;lfel</surname><given-names>R.</given-names></name><etal/></person-group>, <article-title>Virological assessment of hospitalized patients with COVID-2019</article-title>. <source>Nature</source>
<volume>581</volume>, <fpage>465</fpage>&#x02013;<lpage>469</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32235945</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Heesterbeek</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Klinkenberg</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hollingsworth</surname><given-names>T. D.</given-names></name></person-group>, <article-title>How will country-based mitigation measures influence the course of the COVID-19 epidemic?</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>931</fpage>&#x02013;<lpage>934</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32164834</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Keeling</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Rohani</surname><given-names>P.</given-names></name></person-group>, <source>Modeling Infectious Diseases in Humans and Animals</source> (<publisher-name>Princeton University Press</publisher-name>, <year>2008</year>).</mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gardner</surname><given-names>L.</given-names></name></person-group>, <article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title>. <source>Lancet Infect. Dis.</source>
<volume>20</volume>, <fpage>533</fpage>&#x02013;<lpage>534</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32087114</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>H.</given-names></name></person-group>, <article-title>Has Sweden&#x02019;s controversial COVID-19 strategy been successful?</article-title>
<source>BMJ</source>
<volume>369</volume>, <fpage>m2376</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32532807</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haffajee</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Mello</surname><given-names>M. M.</given-names></name></person-group>, <article-title>Thinking globally, acting locally&#x02014;The U.S. response to COVID-19</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, <fpage>e75</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32240580</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scally</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Jacobson</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Abbasi</surname><given-names>K.</given-names></name></person-group>, <article-title>The UK&#x02019;s public health response to COVID-19</article-title>. <source>BMJ</source>
<volume>369</volume>, <fpage>m1932</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32414712</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>D. J.</given-names></name></person-group>, <article-title>COVID-19 and the stiff upper lip&#x02014;The pandemic response in the United Kingdom</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, <fpage>e31</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32197002</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>May</surname><given-names>R. M.</given-names></name></person-group>, <source>Infectious Diseases of Humans: Dynamics and Control</source> (<publisher-name>Oxford University Press</publisher-name>, <year>1992</year>).</mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prem</surname><given-names>K.</given-names></name><etal/></person-group>, <article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: A modelling study</article-title>. <source>Lancet Public Health</source>
<volume>5</volume>, <fpage>e261</fpage>&#x02013;<lpage>e270</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>P. G. T.</given-names></name><etal/></person-group>, <article-title>The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries</article-title>. <source>Science</source>
<volume>369</volume>, <fpage>413</fpage>&#x02013;<lpage>422</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32532802</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>N. G.</given-names></name><etal/></person-group>, <article-title>Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: A modelling study</article-title>. <source>Lancet Public Health</source>
<volume>5</volume>, <fpage>e375</fpage>&#x02013;<lpage>e385</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32502389</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>N.</given-names></name><etal/></person-group>, &#x0201c;<article-title>Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand</article-title>&#x0201d; (Rep. 9, <publisher-name>Imperial College London</publisher-name>, <year>2020</year>).</mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verity</surname><given-names>R.</given-names></name><etal/></person-group>, <article-title>Estimates of the severity of coronavirus disease 2019: A model-based analysis</article-title>. <source>Lancet Infect. Dis.</source>
<volume>20</volume>, <fpage>P669</fpage>&#x02013;<lpage>P677</lpage> (<year>2020</year>).</mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollingsworth</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Klinkenberg</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Heesterbeek</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>R. M.</given-names></name></person-group>, <article-title>Mitigation strategies for pandemic influenza A: Balancing conflicting policy objectives</article-title>. <source>PLoS Comput. Biol.</source>
<volume>7</volume>, <fpage>e1001076</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21347316</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Docherty</surname><given-names>A. B.</given-names></name><etal/></person-group>, <article-title>Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol</article-title>. <comment>medRxiv:10.1101/2020.04.23.20076042 (28 April 2020).</comment></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stringhini</surname><given-names>S.</given-names></name><etal/></person-group>, <article-title>Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): A population-based study</article-title>. <source>Lancet</source>
<volume>396</volume>, <fpage>P313</fpage>&#x02013;<lpage>P319</lpage> (<year>2020</year>).</mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="web"><person-group person-group-type="author"><collab>Office for National Statistics</collab></person-group>, <article-title>Coronavirus (COVID-19) infection survey pilot: 28 May 2020</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/28may2020" xlink:show="new">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/28may2020</ext-link>. Accessed 3 June 2020</comment>.</mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanche</surname><given-names>S.</given-names></name><etal/></person-group>, <article-title>High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2</article-title>. <source>Emerg. Infect. Dis.</source>
<volume>26</volume>, <fpage>1470</fpage>&#x02013;<lpage>1477</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32255761</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horton</surname><given-names>R.</given-names></name></person-group>, <article-title>Offline: COVID-19&#x02014;A reckoning</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>935</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32199478</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kissler</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Tedijanto</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Grad</surname><given-names>Y. H.</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M.</given-names></name></person-group>, <article-title>Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</article-title>. <source>Science</source>
<volume>368</volume>, <fpage>860</fpage>&#x02013;<lpage>868</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32291278</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antia</surname><given-names>A.</given-names></name><etal/></person-group>, <article-title>Heterogeneity and longevity of antibody memory to viruses and vaccines</article-title>. <source>PLoS Biol.</source>
<volume>16</volume>, <fpage>e2006601</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30096134</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Cell&#x000e8;s</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Magpantay</surname><given-names>F. M.</given-names></name>, <name name-style="western"><surname>King</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Rohani</surname><given-names>P.</given-names></name></person-group>, <article-title>The impact of past vaccination coverage and immunity on pertussis resurgence</article-title>. <source>Sci. Transl. Med.</source>
<volume>10</volume>, <fpage>eaaj1748</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29593103</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mossong</surname><given-names>J.</given-names></name><etal/></person-group>, <article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title>. <source>PLoS Med.</source>
<volume>5</volume>, <fpage>e74</fpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18366252</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riolo</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Rohani</surname><given-names>P.</given-names></name></person-group>, <article-title>Combating pertussis resurgence: One booster vaccination schedule does not fit all</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>112</volume>, <fpage>E472</fpage>&#x02013;<lpage>E477</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25605878</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><etal/></person-group>, <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus&#x02013;infected pneumonia</article-title>. <source>N. Engl. J. Med.</source>
<volume>382</volume>, <fpage>1199</fpage>&#x02013;<lpage>1207</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31995857</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><etal/></person-group>, <article-title>Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: A descriptive and modelling study</article-title>. <source>Lancet Infect. Dis.</source>
<volume>20</volume>, <fpage>793</fpage>&#x02013;<lpage>802</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32247326</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linton</surname><given-names>N. M.</given-names></name><etal/></person-group>, <article-title>Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data</article-title>. <source>J. Clin. Med.</source>
<volume>9</volume>, <fpage>538</fpage> (<year>2020</year>).</mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>S. A.</given-names></name><etal/></person-group>, <article-title>The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application</article-title>. <source>Ann. Intern. Med.</source>
<volume>172</volume>, <fpage>577</fpage>&#x02013;<lpage>582</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32150748</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lloyd</surname><given-names>A. L.</given-names></name></person-group>, <article-title>Realistic distributions of infectious periods in epidemic models: Changing patterns of persistence and dynamics</article-title>. <source>Theor. Popul. Biol.</source>
<volume>60</volume>, <fpage>59</fpage>&#x02013;<lpage>71</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11589638</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wearing</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Rohani</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Keeling</surname><given-names>M.</given-names></name></person-group>, <article-title>Appropriate models for the management of infectious diseases</article-title>. <source>PLoS Med.</source>
<volume>2</volume>, <fpage>e174</fpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16013892</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van den Driessche</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Watmough</surname><given-names>J.</given-names></name></person-group>, <article-title>Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission</article-title>. <source>Math. Biosci.</source>
<volume>180</volume>, <fpage>29</fpage>&#x02013;<lpage>48</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12387915</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Brett</surname><given-names>T.</given-names></name></person-group>, <comment>Data for: Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies (Version 2.0.0). Zenodo. </comment><pub-id pub-id-type="doi">10.5281/zenodo.4000983</pub-id><comment>. Deposited 25 August 2020.</comment></mixed-citation></ref></ref-list></back></article>